DIAZEPAM METABOLISM BY HUMAN LIVER-MICROSOMES IS MEDIATED BY BOTH S-MEPHENYTOIN HYDROXYLASE AND CYP3A ISOFORMS

被引:199
作者
ANDERSSON, T [1 ]
MINERS, JO [1 ]
VERONESE, ME [1 ]
BIRKETT, DJ [1 ]
机构
[1] FLINDERS MED CTR,DEPT CLIN PHARMACOL,BEDFORD PK,SA 5042,AUSTRALIA
关键词
DIAZEPAM; HUMAN MICROSOMES; KINETICS; CYP ISOFORMS;
D O I
10.1111/j.1365-2125.1994.tb04336.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The primary metabolism of diazepam was studied in human liver microsomes in order to investigate the kinetics and to identify the cytochrome P450 (CYP) isoforms responsible for the formation of the main diazepam metabolites, temazepam and N-desmethyldiazepam. 2 The formation kinetics of both metabolites were atypical and consistent with the occurrence of substrate activation. A sigmoid V-max model equivalent to the Hill equation was used to fit the data. The degree of sigmoidicity was greater for temazepam formation than for N-desmethyldiazepam formation, so that the ratio of desmethyldiazepam:temazepam formation increased as the substrate (diazepam) concentration decreased. 3 alpha-Naphthoflavone activated both reactions but with a greater effect on temazepam formation than on N-desmethyldiazepam formation. In the presence of 25 mu M alpha-naphthoflavone the kinetics for both pathways were approximated by Michaelis-Menten kinetics. 4 Studies with a series of CYP isoform selective inhibitors and with an inhibitory anti-CYP2C antibody indicated that temazepam formation was carried out mainly by CYP3A isoforms, whereas the formation of N-desmethyldiazepam was mediated by both CYP3A isoforms and S-mephenytoin hydroxylase.
引用
收藏
页码:131 / 137
页数:7
相关论文
共 32 条
[1]   EFFECT OF OMEPRAZOLE TREATMENT ON DIAZEPAM PLASMA-LEVELS IN SLOW VERSUS NORMAL RAPID METABOLIZERS OF OMEPRAZOLE [J].
ANDERSSON, T ;
CEDERBERG, C ;
EDVARDSSON, G ;
HEGGELUND, A ;
LUNDBORG, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (01) :79-85
[2]   IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING OMEPRAZOLE METABOLISM [J].
ANDERSSON, T ;
MINERS, JO ;
VERONESE, ME ;
TASSANEEYAKUL, W ;
TASSANEEYAKUL, W ;
MEYER, UA ;
BIRKETT, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (06) :521-530
[3]   SLOW OMEPRAZOLE METABOLIZERS ARE ALSO POOR S-MEPHENYTOIN HYDROXYLATORS [J].
ANDERSSON, T ;
REGARDH, CG ;
DAHLPUUSTINEN, ML ;
BERTILSSON, L .
THERAPEUTIC DRUG MONITORING, 1990, 12 (04) :415-416
[4]  
Andersson T, 1991, THESIS U GOTEBORG SW
[5]   DIAZEPAM METABOLISM BY RAT AND HUMAN LIVER INVITRO - INHIBITION BY MEPHENYTOIN [J].
BEISCHLAG, TV ;
KALOW, W ;
MAHON, WA ;
INABA, T .
XENOBIOTICA, 1992, 22 (05) :559-567
[6]   FACTORS INFLUENCING THE METABOLISM OF DIAZEPAM [J].
BERTILSSON, L ;
BAILLIE, TA ;
REVIRIEGO, J .
PHARMACOLOGY & THERAPEUTICS, 1990, 45 (01) :85-91
[7]   IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE [J].
BERTILSSON, L ;
HENTHORN, TK ;
SANZ, E ;
TYBRING, G ;
SAWE, J ;
VILLEN, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) :348-355
[8]  
BERTILSSON L, 1992, PHARMACOGENETICS DRU, P729
[9]   EFFECTS AND PLASMA-LEVELS OF N-DESMETHYLDIAZEPAM AFTER ORAL-ADMINISTRATION IN NORMAL VOLUNTEERS [J].
DASBERG, HH .
PSYCHOPHARMACOLOGIA, 1975, 43 (02) :191-198
[10]   RELATIONSHIP BETWEEN PHENYTOIN AND TOLBUTAMIDE HYDROXYLATIONS IN HUMAN LIVER-MICROSOMES [J].
DOECKE, CJ ;
VERONESE, ME ;
POND, SM ;
MINERS, JO ;
BIRKETT, DJ ;
SANSOM, LN ;
MCMANUS, ME .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (02) :125-130